Publications by authors named "Alessandra Damassi"

Claim this Profile
M
Meet-URO Score Validation in Real-world Patients with Metastatic Renal Cell Carcinoma Receiving First-line Pembrolizumab Plus axitinib: A Subanalysis of the Prospective ProPAXI Study.
Giulia Airò, Annalisa Guida, Alessio Gili, Alessio Signori, Sara Elena Rebuzzi, Alessandra Damassi

J Kidney Cancer VHL· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of type of prior TKI in pretreated metastatic renal cell carcinoma patients receiving nivolumab.
Alessandra Damassi, Malvina Cremante, Alessio Signori, Sara Elena Rebuzzi, Andrea Malgeri

Immunotherapy· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of First-Line Abiraterone Acetate or Enzalutamide for Older Adults With Metastatic Castration-Resistant Prostate Cancer According to Use of Upfront Docetaxel for Metastatic Castration-Sensitive Prostate Cancer in an International Multicenter Registry: A SPARTACUSS-Meet-URO 26 Study.
Giuseppe Fotia, Calogero Saieva, Richard Lee-Ying, Anna Patrikidou, Pier Vitale Nuzzo, Alessandra Damassi

Clin Genitourin Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study).
Fabio Catalano, Matteo Brunelli, Alessio Signori, Pasquale Rescigno, Sebastiano Buti, Alessandra Damassi

Future Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study).
Fabio Catalano, Matteo Brunelli, Alessio Signori, Pasquale Rescigno, Sebastiano Buti, Alessandra Damassi

Future Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Stratification by the Meet-URO Score in Real-World Older Patients With Metastatic Renal Cell Carcinoma (mRCC) Receiving Cabozantinib: A Subanalysis of the Prospective ZEBRA Study (Meet-URO 9).
Alessandra Damassi, Malvina Cremante, Alessio Signori, Sara Elena Rebuzzi, Giuseppe Fornarini

Clin Genitourin Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to strategy failure and treatment beyond progression in pretreated metastatic renal cell carcinoma patients receiving nivolumab: analysis of the Meet-URO 15 study.
Veronica Murianni, Alessio Signori, Sebastiano Buti, Sara Elena Rebuzzi, Davide Bimbatti, Alessandra Damassi

Front Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apalutamide-induced lichenoid reaction in a patient with non-metastatic castrate-resistant prostate cancer.
Malvina Cremante, Silvia Puglisi, Annalice Gandini, Antonio Guadagno, Fabio Catalano, Alessandra Damassi

J Oncol Pharm Pract· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel immunotherapy prognostic score for patients with pretreated advanced urInary TrAct CArcinoma from the subgroup analysis of the SAUL study: the ITACA Score.
Giuseppe Fornarini, Sara E Rebuzzi, Sebastiano Buti, Pasquale Rescigno, Axel Merseburger, Alessandra Damassi

Minerva Urol Nephrol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study.
Sara Elena Rebuzzi, Matteo Brunelli, Francesca Galuppini, Valerio Gaetano Vellone, Alessio Signori, Alessandra Damassi

Cancers (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined response of advanced cutaneous squamous cell carcinoma and renal cell carcinoma to immunotherapy: a case report.
Veronica Murianni, Luigi Cerbone, Pasquale Rescigno, Fabio Catalano, Alessandra Damassi

Immunotherapy· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study.
Sara Elena Rebuzzi, Alessio Signori, Giuseppe Luigi Banna, Annalice Gandini, Giuseppe Fornarini, Alessandra Damassi

J Transl Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare anti-VEGFR therapy-induced toxicity and long-term response to immunotherapy in a rare non-clear cell renal cell carcinoma patient.
Fabio Catalano, Sara Elena Rebuzzi, Veronica Murianni, Alessandra Damassi, Valentino Martelli

Anticancer Drugs· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and Predictive Factors in Advanced Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors: A Review of the Current Evidence.
Sara Elena Rebuzzi, Giuseppe Luigi Banna, Veronica Murianni, Alessandra Damassi, Emilio Francesco Giunta

Cancers (Basel)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy retreatment: case report, review of the literature and proposal for the definition of different scenarios.
Roberto Borea, Alessandra Damassi, Sara Elena Rebuzzi, Giuseppe Luigi Banna, Veronica Murianni

Immunotherapy· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender-specific aspects related to type of fertility preservation strategies and access to fertility care.
Marta Perachino, Claudia Massarotti, Maria Grazia Razeti, Francesca Parisi, Luca Arecco, Alessandra Damassi

ESMO Open· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Prognostic Role of Baseline Metabolic Tumor Burden and Systemic Inflammation Biomarkers in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Radium-223: A Proof of Concept Study.
Matteo Bauckneht, Sara Elena Rebuzzi, Alessio Signori, Maria Isabella Donegani, Veronica Murianni, Alessandra Damassi

Cancers (Basel)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burning Questions in the Oncofertility Counseling of Young Breast Cancer Patients.
Luca Arecco, Marta Perachino, Alessandra Damassi, Maria Maddalena Latocca, Davide Soldato

Breast Cancer (Auckl)· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moving trastuzumab emtansine (T-DM1) to the early setting of breast cancer treatment.
Luca Arecco, Eva Blondeaux, Alessandra Damassi, Piero Fregatti, Matteo Lambertini

Ann Palliat Med· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis